GlassScriptPhysician profile
Alexander Volpi
NPI 1093178931
$50,036.70
in general payments reported to CMS, 2019-2025
21 companies · $3,004 in 2025
The $3,004 reported for 2025 was more than what 75% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27K · 2022: $14K · 2023: $3,235 · 2024: $2,419 · 2025: $3,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,930 · Food and Beverage: $3,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,930.46 |
| Food and Beverage | $3,726.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $29,704.31 | 2021-2025 | |
| Smith+Nephew, INC. | $4,891.79 | 2021-2023 | Accu-Pass |
| Micromed INC | $3,728.06 | 2021-2022 | |
| Medical Device Business Services, INC. | $3,484.07 | 2021 | |
| Stryker Corporation | $1,725.89 | 2021-2024 | Iconix, Na, Alphavent |
| Gotham Surgical Solutions & Devices, INC. | $1,698.11 | 2022 | |
| Saxum Surgical, INC. | $1,205.68 | 2022 | |
| Polaris Technology Solutions LLC | $871.34 | 2023-2024 | |
| Depuy Synthes Sales INC. | $656.35 | 2021-2025 | Orthovisc, Monovisc, Va-Lcp |
| Bioventus LLC | $485.64 | 2024-2025 | Gelsyn-3, Durolane |
| Globus Medical, INC. | $482.88 | 2022-2025 | Anthem, Stelkast Generic Knee Instruments |
| Davol INC. | $285.24 | 2021-2022 | |
| Skeletal Dynamics INC | $228.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $142.84 | 2025 | Comprehensive Shoulder System |
| Integra Lifesciences Corporation | $131.82 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $105.36 | 2024 | Biobrace 23mm, Allograft Tissue |
| Catalyst Orthoscience | $84.38 | 2021 | |
| Acumed LLC | $48.73 | 2021 | |
| Ferring Pharmaceuticals INC. | $46.76 | 2022-2025 | Euflexxa |
| Cumberland Pharmaceuticals, INC. | $14.80 | 2023 | Caldolor |
| Convatec INC. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Volpi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.